Optical Preclinical Imaging Market Expected to Reach $859.70 Million by 2030

Optical Preclinical Imaging 2030

Optical preclinical imaging market provides an in-depth analysis and the current trends and future estimations.

PORTLAND, OREGON, UNITED STATES, July 27, 2023/EINPresswire.com/ — Optical imaging device serves as a standard tool in preclinical drug discovery and development. This modality offers a virtual window inside the animals, thus facilitating the tracking of biological activities at the molecular level. This method is simple to use, offers fast throughput, is reasonably priced with outstanding sensitivity, and does not emit radiations. Noninvasive in vivo imaging methods have elevated the use of animal models in preclinical drug discovery and development to a new level, allowing rapid and efficient drug effectiveness screening. During the preclinical stage of drug discovery and development research, in vitro and in vivo testing are performed to ensure that the drug candidate is safe to test in humans prior to the beginning of clinical trials. Animal models are used in preclinical research to help in the exploration of human diseases and the development of novel treatments. The biological relevance of an animal model is crucial for clinical outcome prediction.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Berthold Technologies GmbH & Co.KG
Endress+Hauser (Analytik Jena US LLC)
Fujifilm Corporation (Fujifilm VisualSonics Inc.)
LI-COR Biosciences, Inc.
Miltenyi Biotec
PerkinElmer, Inc.
Rigaku Corporation (MILabs B.V.)
TriFoil Imaging
Vieworks Co., Ltd.
Vilber Smart Imaging Ltd.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/10711

The major objective of preclinical imaging is to enhance the probability of clinical success while shortening the time and expense of drug R&D. Nuclear medicine techniques (primarily positron emission tomography [PET] and single photon emission computed tomography [SPECT]), optical imaging (OI), computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy imaging (MRSI), and ultrasound are the most appropriate modalities for small animal in vivo imaging applications. Each modality has its own set of advantages and disadvantages.

Noninvasive, whole-body in vivo optical imaging enables the monitoring and assessment of diseases, drug biodistribution, and molecular events in small animals by labelling them with light emitting reporters. Tumor cells, stem cells, immunological cells, gene therapy, viruses, or bacteria, for example, can be genetically tagged with a fluorescent protein. The biodistribution of drug delivery nanoparticles and biologicals (for example, antibodies) can be tracked by marking the moiety with a fluorescent dye. In vivo optical imaging can assist researchers to monitor biodistribution, cellular or genetic activity, and utilize the data to track medications, gene expression, disease transmission, or the impacts of a novel drug candidate by monitoring and analyzing light output.

The growth of the optical preclinical imaging market is majorly driven by technological developments in molecular imaging, surge in demand for noninvasive small animal imaging techniques, and increase in public–private efforts, and financing for advanced research. In addition, emergence of new diseases, discovery of new molecules and their clinical trials further boost the growth of the market.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/10711

Depending on end user, the market is differentiated into pharma & biotech companies, academic & government research institutes and contract research organizations. The contract research organizations segment dominated the market in 2020 with $245.30 million and is expected to witness highest CAGR of 5.8% during the forecast period.

North America accounted for a majority of the global optical preclinical imaging market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to increase in adoption of advanced technologies, presence of key players, and rise healthcare expenditure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in R&D activities in preclinical studies, and increase in investments in the healthcare sector in the region.

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

𝐀𝐕𝐄𝐍𝐔𝐄- 𝐀 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐁𝐚𝐬𝐞𝐝 𝐋𝐢𝐛𝐫𝐚𝐫𝐲 (𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝, 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐛𝐚𝐬𝐞𝐝 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐦𝐨𝐝𝐞𝐥) 𝐎𝐟𝐟𝐞𝐫𝐞𝐝 𝐛𝐲 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

𝐆𝐞𝐭 𝐚𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐥𝐢𝐛𝐫𝐚𝐫𝐲 𝐨𝐟 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐚𝐭 𝐚𝐧𝐲 𝐭𝐢𝐦𝐞 𝐟𝐫𝐨𝐦 𝐚𝐧𝐲 𝐝𝐞𝐯𝐢𝐜𝐞 𝐚𝐧𝐝 𝐚𝐧𝐲𝐰𝐡𝐞𝐫𝐞. 𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐝𝐞𝐭𝐚𝐢𝐥𝐬, 𝐟𝐨𝐥𝐥𝐨𝐰 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤: https://www.alliedmarketresearch.com/library-access

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
1 800-792-5285
email us here